Literature DB >> 9185858

Purification and characterization of secreted human leptin produced in baculovirus-infected insect cells.

L M Churgay1, S Kovacevic, F C Tinsley, C M Kussow, R L Millican, J R Miller, J E Hale.   

Abstract

The product of the human ob (obesity) gene, leptin, appears to function in the maintenance of body weight in vivo. When injected into mice, this hormone reduces food consumption and causes weight loss. This work has been done with recombinant leptin (re-leptin) purified and renatured from inclusion bodies in Escherichia coli. We have expressed the human obesity gene encoding the predicted full-length leptin in Spodoptera frugiperda (Sf-9) cells by infection with the recombinant baculovirus system. Protein corresponding to re-leptin was secreted into the culture medium and purified in sufficient quantity for testing biological activity. The secreted re-protein was characterized and found to be unmodified except for correct cleavage of the signal peptide during export from the cells. The resulting molecule is expected to be properly folded and has been purified to a high level of homogeneity. The re-leptin secreted from Sf-9 cells should be an appropriate source of protein for study of the native structure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185858     DOI: 10.1016/s0378-1119(97)00041-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Effects of medium composition on the production of plasmid DNA vector potentially for human gene therapy.

Authors:  Zhi-Nan Xu; Wen-He Shen; Hao Chen; Pei-Lin Cen
Journal:  J Zhejiang Univ Sci B       Date:  2005-05       Impact factor: 3.066

2.  Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity.

Authors:  Dongfen Yuan; Xiang Yi; Yuling Zhao; Chi-Duen Poon; Kristin M Bullock; Kim M Hansen; Therese S Salameh; Susan A Farr; William A Banks; Alexander V Kabanov
Journal:  J Control Release       Date:  2017-03-24       Impact factor: 9.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.